Skip to search formSkip to main contentSkip to account menu

sulfonyl-pyridazinone inhibitor

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyridazinesSulfones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Diverse chemical and biological potentials of various pyridazine and pyridazinone derivatives
ISSN: 2410-9649 Asif et al / Chemistry International 5(3) (2019) 206-231 iscientic.org. 
2014
2014
New antiplatelet and vasorelaxant agents based on the pyridazinone moiety (1054.6)
The pharmacological profile of pyridazinone derivatives includes interesting properties on cardiovascular system as platelet… 
2013
2013
Composé pyridazinone et utilisation associée
La presente invention concerne un compose pyridazinone de formule (I) et son utilisation comme activateur de resistance induite… 
2013
2013
[Cases of successful treatment of heart failure after cardiac surgeries].
UNLABELLED Low cardiac output syndrome (LCOS) is a leader in the structure of complications and mortality in patients after… 
2010
2010
Abstract 5777: EMD 1214063, an exquisitely selective c-Met kinase inhibitor in clinical phase 1
The role of the receptor tyrosin kinase c-Met in tumor progression, metastasis and aggressiveness has been convincingly… 
2006
2006
Derive de pyrazolopyridine-4-yl-pyridazinone, sel d’addition de ce derive et inhibiteur des pde comprenant ce sel ou derive en tant qu’ingredient actif
Le probleme a resoudre dans le cadre de la presente invention consiste a proposer un nouveau derive de pyrazolopyridine-4-yl… 
Review
2002
Review
2002
Arylpiperazines with affinity toward alpha(1)-adrenergic receptors.
In the last years, alpha(1) adrenoceptors (alpha(1)-AR) have been the subject of intense research, in part because receptor… 
2001
2001
Verfahren zur herstellung von sulfonyl-imidazol-derivaten mittels phasentransfer-katalyse
Nach einem neuen Verfahren lassen sich Sulfonyl-imidazol-Derivate der Formel (I), in welcher R, R1, R2 und X die in der… 
1986
1986
UDCG 115 a benzimidazo-pyridazinone compound with cardiovascular activity inhibits platelet thrombus formation
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)